Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,852,775
  • Shares Outstanding, K 142,500
  • Annual Sales, $ 2,340 M
  • Annual Income, $ 315,590 K
  • 36-Month Beta 0.97
  • Price/Sales 6.35
  • Price/Cash Flow 23.70
  • Price/Book 7.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.93
  • Number of Estimates 5
  • High Estimate 0.96
  • Low Estimate 0.89
  • Prior Year 1.00
  • Growth Rate Est. (year over year) -7.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.36 +8.12%
on 10/25/18
108.78 -4.23%
on 11/08/18
-1.83 (-1.73%)
since 10/16/18
3-Month
96.36 +8.12%
on 10/25/18
116.64 -10.68%
on 10/01/18
-2.66 (-2.49%)
since 08/16/18
52-Week
82.81 +25.81%
on 12/01/17
116.64 -10.68%
on 10/01/18
+19.20 (+22.59%)
since 11/16/17

Most Recent Stories

More News
ResMed (RMD) Closes MatrixCare Buyout, Boosts SaaS Line

Post culmination of the transaction, MatrixCare will continue to operate as a standalone business within ResMed's (RMD) SaaS portfolio.

SYK : 172.16 (+2.04%)
VEEV : 92.44 (+0.01%)
RMD : 104.18 (-0.05%)
MASI : 109.65 (+0.79%)
ResMed Completes Acquisition of MatrixCare

--Expands ResMed's SaaS offerings into additional care settings, including skilled nursing and senior living

RMD : 104.18 (-0.05%)
ResMed's Out-of-Hospital Line to Grow With MatrixCare Buyout

MatrixCare consolidation is expected to enhance ResMed's (RMD) capacity to improve patient transitions of care as well as its provider skills.

BABY : 33.93 (+8.06%)
RMD : 104.18 (-0.05%)
MASI : 109.65 (+0.79%)
ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings

--Enhances ResMed's ability to improve patient transitions of care and provider efficiencies

RMD : 104.18 (-0.05%)
Research Report Identifies Charter Communications, Old Dominion Freight Line, CoreLogic, Align Technology, HealthStream, and ResMed with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Charter Communications, Inc....

CLGX : 40.66 (+0.25%)
HSTM : 24.28 (-1.14%)
RMD : 104.18 (-0.05%)
CHTR : 328.54 (+3.16%)
ALGN : 225.41 (+1.19%)
ODFL : 134.65 (-1.07%)
ResMed (RMD) Looks Good: Stock Adds 5.7% in Session

ResMed (RMD) shares rose nearly 6% in the last trading session, amid huge volumes.

RMD : 104.18 (-0.05%)
HAE : 110.80 (+2.34%)
Shares of Resmed Inc Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (RMD , IVC , PODD , CUTR , KTWO )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

IVC : 5.68 (-5.80%)
RMD : 104.18 (-0.05%)
PODD : 81.89 (+0.20%)
ResMed (RMD) Q1 Earnings & Sales Beat on Overall Growth

ResMed (RMD) sees solid contributions from domestic and international businesses in Q1.

AMED : 125.91 (+3.21%)
RMD : 104.18 (-0.05%)
MASI : 109.65 (+0.79%)
BAX : 66.51 (+1.03%)
ResMed (RMD) Q1 Earnings and Revenues Surpass Estimates

ResMed (RMD) delivered earnings and revenue surprises of 1.25% and 2.02%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

RMD : 104.18 (-0.05%)
ResMed: Fiscal 1Q Earnings Snapshot

SAN DIEGO (AP) _ ResMed Inc. (RMD) on Thursday reported fiscal first-quarter profit of $105.7 million.

RSMDF : 10.4000 (-2.35%)
RMD : 104.18 (-0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade RMD with:

Business Summary

ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions....

See More

Key Turning Points

2nd Resistance Point 107.03
1st Resistance Point 105.60
Last Price 104.18
1st Support Level 102.54
2nd Support Level 100.91

See More

52-Week High 116.64
Last Price 104.18
Fibonacci 61.8% 103.72
Fibonacci 50% 99.72
Fibonacci 38.2% 95.73
52-Week Low 82.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar